comparemela.com

Latest Breaking News On - Redchip financial communications united states - Page 4 : comparemela.com

Aptorum Group Limited Interview to Air on Bloomberg U S on the RedChip Money Report

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group" or "Aptorum"), a clinical-stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology

United statesDarren luiGhislaine gasparettoAptorum group formAptorum group orTechnologies pte ltdInvestor relations departmentSingapore agency for scienceActifin financial communications europeRedchip financial communications united statesDaptorum groupAptorum group limited nasdaqRegulatory newsGroup limitedEuronext parisRedchip money report

Aptorum Group Limited: Aptorum Group Receives FDA Orphan Drug Designation for its SACT-1 Repurposed Drug For The Treatment of Neuroblastoma

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group" or "Aptorum"), a clinical-stage biopharmaceutical company, is pleased to announce that the United States

United statesDarren luiGhislaine gasparettoAptorum group formAptorum group orTechnologies pte ltdInvestor relations departmentDrug administrationSingapore agency for scienceActifin financial communications europeRedchip financial communications united statesDaptorum groupAptorum group limited nasdaqAmerican cancer societyRegulatory newsGroup limited

Aptorum Group Limited: Aptorum Group Granted The First Patent for its SACT-1 Repurposed Drug For Treatment of Various Cancer Including but Not Limited to Neuroblastoma

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group" or "Aptorum"), a clinical-stage biopharmaceutical company, is pleased to announce that the US Patent and

Darren luiGhislaine gasparettoAptorum group formAptorum group orTechnologies pte ltdInvestor relations departmentSingapore agency for scienceActifin financial communications europeRedchip financial communications united statesDaptorum groupTrademark officeAptorum group limited nasdaqRegulatory newsGroup limitedEuronext parisExecutive director

Aptorum Group Limited Announces Results of 2021 Annual General Meeting of Shareholders

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group" or "Aptorum"), a clinical stage biopharmaceutical company focused on novel technologies including the targeting

Hong kongCayman islandsDouglas arnerDarren luiClark chengCharles bathurstGhislaine gasparettoIan huenMirko schererJustin wuAptorum group formAptorum group orTechnologies pte ltdArticles of associationInvestor relations departmentSingapore agency for science

Aptorum Group Limited Interview to Air on Bloomberg U S

Regulatory News: Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM), a clinical stage biopharmaceutical company focused on novel technologies including the targeting of oncological diseases

Darren luiGhislaine gasparettoAptorum group formTechnologies pte ltdInvestor relations departmentSingapore agency for scienceActifin financial communications europeRedchip financial communications united statesDaptorum groupAptorum group limited nasdaqAptorum group limitedRegulatory newsGroup limitedEuronext parisPresident darren luiRedchip money

vimarsana © 2020. All Rights Reserved.